Sagent Pharmaceuticals Inc. (SGNT) Insider Robert Flanagan Sells 16,000 SharesBy Melanie MarilinJuly 21, 2014 Robert Flanagan, Director at Sagent Pharmaceuticals Inc. (NASDAQ:SGNT), completed a stock disposition of 16,000 shares on Friday. The Common Stock…